DK1401404T3 - Fremgangsmåde til indkapsling af et aktivt stof - Google Patents

Fremgangsmåde til indkapsling af et aktivt stof

Info

Publication number
DK1401404T3
DK1401404T3 DK02735680T DK02735680T DK1401404T3 DK 1401404 T3 DK1401404 T3 DK 1401404T3 DK 02735680 T DK02735680 T DK 02735680T DK 02735680 T DK02735680 T DK 02735680T DK 1401404 T3 DK1401404 T3 DK 1401404T3
Authority
DK
Denmark
Prior art keywords
active substance
inter
coating
product
encapsulating
Prior art date
Application number
DK02735680T
Other languages
English (en)
Inventor
Francis Sean Moolman
Heidi Rolfes
Der Merwe Thilo Lothar Van
Original Assignee
Csir
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=25589180&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK1401404(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Csir filed Critical Csir
Application granted granted Critical
Publication of DK1401404T3 publication Critical patent/DK1401404T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
    • A61K9/2081—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets with microcapsules or coated microparticles according to A61K9/50
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
    • A61K47/58—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. poly[meth]acrylate, polyacrylamide, polystyrene, polyvinylpyrrolidone, polyvinylalcohol or polystyrene sulfonic acid resin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
    • A61K47/59—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyureas or polyurethanes
    • A61K47/60—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyureas or polyurethanes the organic macromolecular compound being a polyoxyalkylene oligomer, polymer or dendrimer, e.g. PEG, PPG, PEO or polyglycerol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1635—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1641—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, poloxamers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1682—Processes
    • A61K9/1694—Processes resulting in granules or microspheres of the matrix type containing more than 5% of excipient
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Manufacturing Of Micro-Capsules (AREA)
  • Processes Of Treating Macromolecular Substances (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Extraction Or Liquid Replacement (AREA)
  • Medicinal Preparation (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Paints Or Removers (AREA)
  • Saccharide Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Processing And Handling Of Plastics And Other Materials For Molding In General (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
DK02735680T 2001-05-30 2002-05-28 Fremgangsmåde til indkapsling af et aktivt stof DK1401404T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
ZA200104451 2001-05-30
PCT/IB2002/001853 WO2003013478A2 (en) 2001-05-30 2002-05-28 Method of encapsulating an active substance

Publications (1)

Publication Number Publication Date
DK1401404T3 true DK1401404T3 (da) 2008-08-11

Family

ID=25589180

Family Applications (1)

Application Number Title Priority Date Filing Date
DK02735680T DK1401404T3 (da) 2001-05-30 2002-05-28 Fremgangsmåde til indkapsling af et aktivt stof

Country Status (20)

Country Link
US (1) US7641917B2 (da)
EP (1) EP1401404B1 (da)
JP (1) JP4313196B2 (da)
CN (1) CN1255099C (da)
AT (1) ATE392203T1 (da)
AU (1) AU2002310567B2 (da)
BR (1) BR0210000A (da)
CA (1) CA2455208C (da)
CH (1) CH695418A5 (da)
CY (1) CY1108199T1 (da)
DE (2) DE60226140T2 (da)
DK (1) DK1401404T3 (da)
ES (1) ES2305250T3 (da)
FR (1) FR2825292B1 (da)
GB (1) GB2392619B (da)
IT (1) ITMI20021169A1 (da)
NL (1) NL1020706C2 (da)
PT (1) PT1401404E (da)
WO (1) WO2003013478A2 (da)
ZA (1) ZA200309983B (da)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE60226140T2 (de) 2001-05-30 2009-05-07 Csir, Pretoria Verfahren zur verkapselung eines wirkstoffs
US7903319B2 (en) * 2006-07-11 2011-03-08 E Ink Corporation Electrophoretic medium and display with improved image stability
US20080082764A1 (en) * 2006-10-03 2008-04-03 Yi Feng Jang Memory accessing system and method
GB0812742D0 (en) 2008-07-11 2008-08-20 Critical Pharmaceuticals Ltd Process
GB201317756D0 (en) 2013-10-08 2013-11-20 Critical Pharmaceuticals Ltd New process
DE102018210030A1 (de) * 2018-06-20 2019-12-24 Thyssenkrupp Ag Verwendung und Recyclieren von überkritischen CO2 als Lösungsmittel für PLA und weitere biologisch abbaubaren Polymere in das Beschichtungsverfahren für Düngemittel
IT201800007993A1 (it) * 2018-08-09 2020-02-09 Greenbone Ortho Srl Impianto finalizzato alla trasformazione chimica di materiali nello stato 3d
CN112812355B (zh) * 2020-12-31 2022-09-23 厦门天生爱科技有限公司 一种具有缓释挥发性中草药有效成分的功能高分子发泡材料、制备方法和用途

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8500121D0 (en) 1985-01-03 1985-02-13 Connaught Lab Microencapsulation of living cells
ATE94782T1 (de) * 1987-12-21 1993-10-15 Union Carbide Corp Verwendung von superkritischen fluessigkeiten als verduenner beim aufspruehen von ueberzuegen.
EP0706821A1 (en) * 1994-10-06 1996-04-17 Centre De Microencapsulation Method of coating particles
US5939485A (en) * 1995-06-19 1999-08-17 Medlogic Global Corporation Responsive polymer networks and methods of their use
DE69617245T2 (de) * 1995-08-17 2002-07-25 Csir, Pretoria Produkte mit gesteuerter freisetzung
FR2753639B1 (fr) 1996-09-25 1998-12-11 Procede de preparation de microcapsules de matieres actives enrobees par un polymere et nouvelles microcapsules notamment obtenues selon le procede
US5766637A (en) 1996-10-08 1998-06-16 University Of Delaware Microencapsulation process using supercritical fluids
US6221300B1 (en) * 1997-02-17 2001-04-24 Doppel Co., Ltd. Method for manufacturing artificial stone
GB9800936D0 (en) 1997-05-10 1998-03-11 Univ Nottingham Biofunctional polymers
CA2306215C (en) 1997-10-15 2010-06-22 University Of South Florida Supercritical fluid aided coating of particulate material
IT1296464B1 (it) * 1997-11-19 1999-06-25 Vectorpharma Int Composizioni farmaceutiche in forma di polveri di polimeri reticolati caricati con farmaci e relativo processo di preparazione mediante
GB9814619D0 (en) 1998-07-06 1998-09-02 Cole Polytechnique Fudurale De Materials and methods relating to encapsulation
US6340722B1 (en) 1998-09-04 2002-01-22 The University Of Akron Polymerization, compatibilized blending, and particle size control of powder coatings in a supercritical fluid
US6350786B1 (en) * 1998-09-22 2002-02-26 Hoffmann-La Roche Inc. Stable complexes of poorly soluble compounds in ionic polymers
GB9920558D0 (en) * 1999-08-31 1999-11-03 Bradford Particle Design Ltd Methods for particle formation and their products
US6372259B1 (en) * 1999-11-10 2002-04-16 University Of Iowa Research Foundation Palatable, sustained release drug granules
AU2001285242A1 (en) 2000-09-08 2002-03-22 Ferro Corporation Controlled-release pharmaceuticals prepared by supercritical fluid processing techniques
US6521258B1 (en) * 2000-09-08 2003-02-18 Ferro Corporation Polymer matrices prepared by supercritical fluid processing techniques
DE60226140T2 (de) 2001-05-30 2009-05-07 Csir, Pretoria Verfahren zur verkapselung eines wirkstoffs

Also Published As

Publication number Publication date
GB0327381D0 (en) 2003-12-31
PT1401404E (pt) 2008-07-23
CA2455208C (en) 2009-02-03
WO2003013478A3 (en) 2003-05-30
CN1512877A (zh) 2004-07-14
ITMI20021169A0 (it) 2002-05-30
CN1255099C (zh) 2006-05-10
FR2825292A1 (fr) 2002-12-06
CA2455208A1 (en) 2003-02-20
EP1401404A2 (en) 2004-03-31
HK1066488A1 (zh) 2005-03-24
FR2825292B1 (fr) 2006-06-09
DE10296849T5 (de) 2004-04-29
CH695418A5 (de) 2006-05-15
DE60226140T2 (de) 2009-05-07
ES2305250T3 (es) 2008-11-01
WO2003013478A2 (en) 2003-02-20
BR0210000A (pt) 2004-05-04
AU2002310567B2 (en) 2005-10-20
ATE392203T1 (de) 2008-05-15
GB2392619A (en) 2004-03-10
ITMI20021169A1 (it) 2003-12-01
CY1108199T1 (el) 2014-02-12
JP4313196B2 (ja) 2009-08-12
US20050112205A1 (en) 2005-05-26
JP2005502642A (ja) 2005-01-27
EP1401404B1 (en) 2008-04-16
DE60226140D1 (de) 2008-05-29
GB2392619B (en) 2004-10-20
NL1020706C2 (nl) 2003-04-28
NL1020706A1 (nl) 2002-12-03
WO2003013478A8 (en) 2003-04-03
US7641917B2 (en) 2010-01-05
ZA200309983B (en) 2005-01-26

Similar Documents

Publication Publication Date Title
WO2002060578A1 (fr) Dispositif servant a activer une substance au moyen d'une structure active et dispositif servant a generer un gaz
ATE324102T1 (de) Pulververarbeitung mit unter druck stehenden gasförmigen fluids
DE69525726D1 (de) Glatte dünne Film-Pulverbeschichtung
WO2004058218A3 (en) Prefilming atomizer
JP2005535347A5 (da)
SE9801287D0 (sv) Incorporation of active substances in carrier matrixes
WO2003051286A3 (en) Hydrogel compositions, devices, and microscale components
AU7964701A (en) Particle trap for separating particles from the flow of a liquid, method for separating particles from the flow of liquid and use of said particle trap
DK1519717T3 (da) Sammensætning til kontrolleret frisætning
WO2005023923A3 (en) Methods of processing nanocrystals, and compositions, devices and systems including same
EP1494840A4 (en) MILL
DK1401404T3 (da) Fremgangsmåde til indkapsling af et aktivt stof
CY1110569T1 (el) Συσκευη και μεθοδος για την απομονωση παραγομενων σωματιδιων ως ενα εναιωρημα σε ενα μη-υπερκρισιμο ρευστο
MXPA03007635A (es) P-tienilbencilamidas que sirven como agonistas de receptores para angiotensina-(1-7), metodo para su produccion, su uso y preparaciones farmaceuticas que las contienen.
ES2174457T3 (es) Produccion de granulados detergentes.
DE69932182D1 (de) Präparationen, die virus-ähnliche partikel als immunpotentiatoren enthalten und durch die schleimhaut verabreicht werden.
SE0303476D0 (sv) Device, method and use for the formation of small particles
BR0213220A (pt) Processo de preparação de compostos de interação de uma substância ativa pouco solúvel em um meio aquoso com um suporte poroso, e, composto de interação de interação de uma substância ativa pouco solúvel em um meio aquoso em um suporte aquoso
TW200609036A (en) Process for coating powders
WO2002024343A3 (de) Verfahren zur herstellung einer beschichtung auf porösen und/oder saugfähigen materialien
WO2008054412A3 (en) Method and apparatus for forming chromonic nanoparticles
SE9501917D0 (sv) Sätt att åstadkomma en motströmsprocess
WO2003031319A3 (de) Adhäsionsverminderte mikromechanische bauelemente
WO2003030867A3 (fr) Procede de preparation d'un compose d'interaction d'un derive anilide avec un support poreux par fluide supercritique
WO2002083259A3 (de) Verfahren und vorrichtung zur stofftrennung